Zanamivir for dengue that causes warning signs
Treatments studied
Part of Infections clinical trials.
This Phase 2 study tests whether zanamivir given through a vein can improve outcomes in people with dengue infection who have warning signs. It may help by reducing the body problems dengue can cause in blood vessels and fluid balance.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You can sign a study consent form and follow all study steps for the full study time
- You are at least 8 years old (age over 7)
- You can get medicine through a vein and take the study medication as planned
- A rapid dengue NS1 test was positive, and you had fever over 38°C in the last 3 days
- Your dengue has warning signs (like severe belly pain, ongoing vomiting, fluid buildup, bleeding, unusual sleepiness or restlessness, enlarged liver, high hematocrit, low platelets, or severe dengue)
- You have Colombian public health insurance through EPS or SGSSS
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests two doses of a dengue vaccine in healthy infants and toddlers aged 6 to 21 months. It aims to see if the vaccine is safe and helps protect against dengue fever.
This study looks at why some people with dengue need to be hospitalized or get a blood transfusion. It aims to make care safer and help doctors know who needs closer monitoring.
This trial tests whether a new medicine called Resomelagon can safely treat dengue fever. It looks at how well the medicine works and if it helps you recover faster.
This study tests if a dengue vaccine (TDV) can reduce hospital stays for dengue. It follows children and teens in areas where dengue vaccination is planned.
This study tests a dengue vaccine (TDV) in adults aged 45 to 79. It aims to see if the vaccine is safe and effective, even for people with common health conditions like diabetes or high blood pressure.
This trial tests new strategies to treat dengue, ranging from mild to severe cases. It may help people with different stages of dengue find better care and support.
Hear when a new Dengue Fever trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.